Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?
Published inRadiation Oncology, vol. 13, no. 1, 114
Publication date2018
Abstract
Research group
Citation (ISO format)
DUBOULOZ, Angèle et al. Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon? In: Radiation Oncology, 2018, vol. 13, n° 1, p. 114. doi: 10.1186/s13014-018-1059-1
Main files (1)
Article (Published version)
![accessLevelPublic](assets/images/access-level-free.png)
Identifiers
- PID : unige:111076
- DOI : 10.1186/s13014-018-1059-1
- PMID : 29921291
ISSN of the journal1748-717X